Drugs / CRCL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01995227 | Dec 2013 → Feb 2018 | hepatocellular carcinoma | Mirror Biologics, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRCL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01995227 ↗ |
| Modality | Vaccine | “personalized Chaperone Rich Cell Lysate (CRCL) vaccine” NCT01995227 ↗ |